<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04735640</url>
  </required_header>
  <id_info>
    <org_study_id>PI18/01209</org_study_id>
    <nct_id>NCT04735640</nct_id>
  </id_info>
  <brief_title>Effectiveness of a Nurse-led Personalized Telephone Intervention on Lifestyle Changes in Diabetes Prevention.</brief_title>
  <acronym>PREDIPHONE</acronym>
  <official_title>Effects of a 9-months Nurse-led Telephone Personalized Lifestyle Intervention Versus Automated SMSs on Nutritional and Physical Activity Advice on Glucose Profile in Patients With Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of the Balearic Islands</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Instituto de Salud Carlos III</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of the Balearic Islands</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized, 9-months, parallel-group study comparing the effectiveness of a nurse-led&#xD;
      telephone personalized lifestyle intervention versus automated SMSs on nutritional and&#xD;
      physical activity advice in the reduction of fasting blood glucose and/or HbA1c in a&#xD;
      population with prediabetes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is estimated that about 70% of the prediabetic population will eventually develop type 2&#xD;
      diabetes (T2DM), contributing to the significant economic burden on health systems and&#xD;
      societies. When prediabetes is recognized, lifestyle intervention including weight loss&#xD;
      through diet and exercise can reduce the relative risk of developing T2DM by more than 50%&#xD;
      within 3 years. In the context of the current pandemic caused by COVID-19 the implementation&#xD;
      of prevention strategies is heavily affected. Telemedicine consultations give patients the&#xD;
      opportunity to receive personalized advice on disease prevention even in times of pandemic.&#xD;
      Previous studies on telemedicine intervention strategies for the prevention of T2DM show that&#xD;
      there is a need to further explore the utility of telemedicine and especially telephone-based&#xD;
      personalized behavioural interventions in patients with prediabetes.The aim of the present&#xD;
      research is to determine whether a nurse-led personalized telephone lifestyle intervention is&#xD;
      effective in reducing risk factors associated with the development of T2DM in subjects with&#xD;
      prediabetes, versus automated short message service (SMS).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">October 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in fasting plasma glucose</measure>
    <time_frame>at baseline, 4, 9, and 15 months</time_frame>
    <description>Change in fasting plasma glucose at 4, 9, and 15 months versus baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood levels of HbA1c</measure>
    <time_frame>at baseline, 4, 9, and 15 months</time_frame>
    <description>Change in HbA1c levels at 4, 9, and 15 months versus baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maintenance of acquired dietary and physical activity changes</measure>
    <time_frame>15 month</time_frame>
    <description>Whether lifestyle changes acquired during the 9-month active-intervention phase are maintained in the mid-term.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Prediabetic State</condition>
  <arm_group>
    <arm_group_label>Nurse-led teleconsultation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>9-month nurse-led telephone-based personalized behavioural intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SMS group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Behavioural intervention by means of short text messages.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>nurse-led teleconsultation</intervention_name>
    <description>Patients assigned to this group will receive personalized dietary and physical activity advice during 9 months. Behavioural goals and action plans will be developed in a stepwise manner in accordance with baseline levels of nutritional and physical activity adherence to recommendations.</description>
    <arm_group_label>Nurse-led teleconsultation group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMS</intervention_name>
    <description>Patients assigned to this group will receive a total of 150 text messages (4 to 5 messages per week during weekdays) throughout the intervention period (9 months). The content of the text messages includes advice on diet and exercise.</description>
    <arm_group_label>SMS group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fasting plasma glucose between 100 and 125 mg/dL OR HbA1c between 5.7 and 6.4%&#xD;
&#xD;
          -  BMI â‰¥ 27 and &lt; 40 kg/m2&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented history of T2DM or use of oral antidiabetic medication&#xD;
&#xD;
          -  Terminal illness&#xD;
&#xD;
          -  Institutionalization, dementia or cognitive impairment&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Major surgery or hospital stay during the previous 3 months&#xD;
&#xD;
          -  Documented history of hematologic disease which may interfere with the HbA1c&#xD;
             measurement&#xD;
&#xD;
          -  Presence of any medical or psychological condition that may limit the ability of the&#xD;
             patient to participate in the study&#xD;
&#xD;
          -  Concomitant active participation in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miquel Bennasar Veny, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of the Balearic Islands</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miquel Bennasar Veny, PhD</last_name>
    <phone>+34 971172367</phone>
    <email>miquel.bennasar@uib.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aina M Yanez Juan, PhD</last_name>
    <phone>+34 971172914</phone>
    <email>aina.yanez@uib.es</email>
  </overall_contact_backup>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>January 29, 2021</last_update_submitted>
  <last_update_submitted_qc>January 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of the Balearic Islands</investigator_affiliation>
    <investigator_full_name>Josep1</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>prediabetes</keyword>
  <keyword>type 2 diabetes</keyword>
  <keyword>fasting plasma glucose</keyword>
  <keyword>diet</keyword>
  <keyword>physical activity</keyword>
  <keyword>randomized clinical trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

